Adjunctive Cenobamate for the Treatment of Primary Generalized Tonic-Clonic Seizures in Adults and Adolescents: Design of a Phase 3 Study With Open-Label Extension (P8-9.017)
YKP3089C025 (Study C025, NCT03678753) is designed to assess the efficacy and safety of adjunctive cenobamate for the treatment of primary generalized tonic-clonic (PGTC) seizures.
Authors
- Sunita N. Misra (ORCID: https://orcid.org/0000-0002-7624-8825)
- Louis Ferrari (ORCID: https://orcid.org/0000-0002-7060-6142)
- Arkady Nisman (ORCID: https://orcid.org/0000-0002-2456-4439)
Institutions
- SK Life Science (United States) (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000208535
- Primary Topic
- Cardiovascular Syncope and Autonomic Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00